Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS)
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety of two different dose regimens of
unfractionated heparin (UFH) during a percutaneous coronary intervention (PCI) procedure in
patients with UA (unstable angina)/NSTEMI (non ST segment elevation myocardial infarction)
who have been initially treated with fondaparinux.